» Authors » Antonella Giampietro

Antonella Giampietro

Explore the profile of Antonella Giampietro including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 74
Citations 677
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Demarchis L, Chiloiro S, Giampietro A, De Marinis L, Bianchi A, Fleseriu M, et al.
Rev Endocr Metab Disord . 2025 Mar; PMID: 40088375
Acromegaly is a rare condition, and often diagnosis is delayed by several years, for most patients. Acromegaly is characterized by short and long-term respiratory, cardiovascular and metabolic comorbidities, with possible...
2.
Chiloiro S, Mattogno P, Angelini F, Giampietro A, Vicari A, Konini G, et al.
Pituitary . 2025 Mar; 28(2):37. PMID: 40064752
Introduction: Cytokine and chemokines have been recognized to be involved in the progression and prognosis of pituitary adenoma/neuroendocrine tumors (PAs/PitNETs), also known as pituitary adenomas. We aim to investigate the...
3.
Sanctis S, Chiloiro S, Tanzarella E, Bongiovanni F, Giampietro A, Infante A, et al.
Endocr Metab Immune Disord Drug Targets . 2025 Mar; PMID: 40045849
Introduction: Sepsis is an illness characterized by a high-stress condition for patients, accompanied by alterations in biochemical processes, behavior, and levels of consciousness. Hormonal alterations that can be seen in...
4.
Padovano Sorrentino F, Chiloiro S, Giampietro A, Bianchi A, Pontecorvi A, De Marinis L
Pituitary . 2024 Dec; 28(1):13. PMID: 39738761
Introduction: Empty sella is characterized by a flattened profile of the pituitary gland that represents in most cases only a radiological incidental finding. When endocrine, ophthalmic, and neurological symptoms occur,...
5.
Chiloiro S, Giampietro A, Giambo P, Costanza F, Mattogno P, Lauretti L, et al.
Pituitary . 2024 Dec; 28(1):7. PMID: 39724447
Introduction: First-generation somatostatin receptor ligands (fg-SRLs) are the cornerstone of acromegaly treatment. Additional benefits were shown using high dose (HD) or high frequency (HF), relatively short-term regimens. Although several predictors...
6.
Costanza F, Giampietro A, Tartaglione T, Angelini F, Gaudino S, De Marinis L, et al.
Endocr Metab Immune Disord Drug Targets . 2024 Sep; PMID: 39318010
Introduction: Hypophysitis is a rare inflammatory disorder of the pituitary gland. Symptoms and signs of hypophysitis can be various, progressing insidiously, and its recognition may be challenging. Case Presentation: We...
7.
Chiloiro S, Costanza F, Giampietro A, Infante A, Mattogno P, Angelini F, et al.
Front Endocrinol (Lausanne) . 2024 Sep; 15:1414101. PMID: 39280003
Background: Skeletal fragility is characterized by increased frequency of vertebral fractures (VFs) in acromegaly. Several trials were conducted to identify modifiable risk factors and predictors of VFs, with limited data...
8.
Chiloiro S, Costanza F, Riccardi E, Giampietro A, De Marinis L, Bianchi A, et al.
Pituitary . 2024 Aug; 27(6):847-859. PMID: 39180644
The evidence that pituitary hormones may bypass peripheral endocrine glands to exert remarkable effects on the skeleton is gaining ground. Both hormonal excess and deficit may determine impairment in bone...
9.
Chiloiro S, Vicari A, Mongelli G, Costanza F, Giampietro A, Mattogno P, et al.
Rev Endocr Metab Disord . 2024 Aug; 25(5):855-873. PMID: 39168952
Secondary adrenal insufficiency (SAI) is an endocrine disorder due to impaired secretion of ACTH resulting from any disease affecting the pituitary gland. Glucocorticoid replacement therapy is mandatory to ensure patient...
10.
Sanctis S, Chiloiro S, Tanzarella E, Bongiovanni F, Giampietro A, De Pascale G, et al.
Endocr Metab Immune Disord Drug Targets . 2024 Jul; PMID: 39082178
Background: The pseudo-Cushing's encompass several disorders that can occur in high-stress situations and that show biochemical features like those of Cushing's syndrome. We present a case with difficult differential diagnosis...